Telomerase in the ovary

Reproduction

Volumn 140, Issue 2, 2010, Pages 215-222

  Liu, Jun Ping ^a   Li, He ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; TELOMERASE;

BLASTOCYST; CARCINOGENESIS; CELL PROLIFERATION; CELL REGENERATION; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ESTROGEN ACTIVITY; FEMALE FERTILITY; FERTILIZATION; GRANULOSA CELL; HUMAN; NONHUMAN; OOCYTE DEVELOPMENT; OVARY; OVARY CANCER; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; REVIEW; TELOMERE; TISSUE REGENERATION; TRANSCRIPTION INITIATION;

CELL PROLIFERATION; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRANULOSA CELLS; HUMANS; OOGENESIS; OVARIAN NEOPLASMS; OVARY; TELOMERASE; TELOMERE;

EID: 77955402694     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-10-0008     Document Type: Review

References (95)

1. Adhikari D & Liu K 2009 Molecular mechanisms underlying the activation of mammalian primordial follicles. Endocrine Reviews 30 438-464.
2. Alvero AB, Fishman DA, Qumsiyeh MB, Garg M, Kacinski BM & Sapi E 2004 Telomerase prolongs the lifespan of normal human ovarian surface epithelial cells without inducing neoplastic phenotype. Journal of the Society for Gynecologic Investigation 11 553-561. (Pubitemid 39586774)
3. Auersperg N, Wong AST, Choi K-C, Kang SK & Leung PCK 2001 Ovarian surface epithelium: biology, endocrinology, and pathology. Endocrine Reviews 22 255-288.
4. Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME & Nicosia SV 2000 Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cellular & Developmental Biology. Animal 36 657-666.
5. Bapat SA, Mali AM, Koppikar CB & Kurrey NK 2005 Stem and progenitorlike cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Research 65 3025-3029.
6. Baykal A, Thompson JA, Xu XC, Hahn WC, Deavers MT, Malpica A, Gershenson DM, Silva EG & Liu J 2004 In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues. Oncology Reports 11 297-302.
7. Bayne S & Liu JP 2005 Hormones and growth factors regulate telomerase activity in ageing and cancer. Molecular and Cellular Endocrinology 240 11-22.
8. Bayne S, Jones ME, Li H & Liu JP 2007 Potential roles for estrogen regulation of telomerase activity in aging. Annals of the New York Academy of Sciences 1114 48-55. (Pubitemid 350070390)
9. Betts DH & King WA 1999 Telomerase activity and telomere detection during early bovine development. Developmental Genetics 25 397-403.
10. Bjornstrom L & Sjoberg M 2005 Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Molecular Endocrinology 19 833-842.
11. Blackburn EH 2001 Switching and signaling at the telomere. Cell 106 661-673.
12. Blasco MA, Funk W, Villeponteau B & Greider CW 1995 Functional characterization and developmental regulation of mouse telomerase RNA. Science 269 1267-1270.
13. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA & Greider CW 1997 Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91 25-34. (Pubitemid 27431310)
14. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu C-P, Morin GB, Harley CB, Shay JW, Lichtsteiner S & Wright WE 1998 Extension of lifespan by introduction of telomerase into normal human cells. Science 279 349-352.
15. Butts S, Riethman H, Ratcliffe S, Shaunik A, Coutifaris C & Barnhart K 2009 Correlation of telomere length and telomerase activity with occult ovarian insufficiency. Journal of Clinical Endocrinology and Metabolism 94 4835-4843.
16. Cassar L, Nicholls C, Pinto AR, Li H & Liu JP 2009 Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3. FASEB Journal 23 1880-1892.
17. Chow SN, Chien CH & Chen CT 1996 Molecular biology of human ovarian cancer. International Surgery 81 152-157. (Pubitemid 26355928)
18. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ & Reddel RR 2007 Protein composition of catalytically active human telomerase from immortal cells. Science 315 1850-1853.
19. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB & Bacchetti S 1992 Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO Journal 11 1921-1929.
20. Counter CM, Hirte HW, Bacchetti S & Harley CB 1994 Telomerase activity in human ovarian carcinoma. PNAS 91 2900-2904. (Pubitemid 24130141)
21. Couse JF, Curtis Hewitt S & Korach KS 2000 Receptor null mice reveal contrasting roles for estrogen receptor a and b in reproductive tissues. Journal of Steroid Biochemistry and Molecular Biology 74 287-296.
22. Davies BR, Steele IA, Edmondson RJ, Zwolinski SA, Saretzki G, von Zglinicki T & O'Hare MJ 2003 Immortalisation of human ovarian surface epithelium with telomerase and temperature-sensitive SV40 large T antigen. Experimental Cell Research 288 390-402.
23. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P & Mark M 2000 Effect of single and compound knockouts of estrogen receptors alpha (ERa) and beta (ERb) on mouse reproductive phenotypes. Development 127 4277-4291.
24. Eisenhauer KM, Gerstein RM, Chiu CP, Conti M & Hsueh AJ 1997 Telomerase activity in female and male rat germ cells undergoing meiosis and in early embryos. Biology of Reproduction 56 1120-1125.
25. Fan H-Y, Liu Z, Cahill N & Richards JS 2008 Targeted disruption of Pten in ovarian granulosa cells enhances ovulation and extends the life span of luteal cells. Molecular Endocrinology 22 2128-2140.
26. Geisler JP, Wiemann MC, Miller GA & Geisler HE 1996 Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary. Gynecologic Oncology 60 424-427.
27. Gleicher N, Weghofer A, Oktay K & Barad D 2009 Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)? Human Reproduction 24 2395-2400.
28. Gorham H, Yoshida K, Sugino T, Marsh G, Manek S, Charnock M, Tarin D & Goodison S 1997 Telomerase activity in human gynaecological malignancies. Journal of Clinical Pathology 50 501-504.
29. Grasselli A, Nanni S, Colussi C, Aiello A, Benvenuti V, Ragone G, Moretti F, Sacchi A, Bacchetti S, Gaetano C et al. 2008 Estrogen receptor-a and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circulation Research 103 34-42.
30. Greenberg RA, Allsopp RC, Chin L, Morin GB & DePinho RA 1998 Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16 1723-1730. (Pubitemid 28175053)
31. Greider CW & Blackburn EH 1985 Identification of a specific telomere terminal transferase enzyme with two kinds of primer specificity. Cell 51 405-413.
32. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H & de Lange T 1999 Mammalian telomeres end in a large duplex loop. Cell 97 503-514.
33. Hande MP, Samper E, Lansdorp P & Blasco MA 1999 Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. Journal of Cell Biology 144 589-601.
34. Herrera E, Samper E & Blasco MA 1999 Telomere shortening in mTRK/K embryos is associated with failure to close the neural tube. EMBO Journal 18 1172-1181. (Pubitemid 29110302)
35. Huang J, Li X, Yi P, Hilf R, Bambara RA & Muyan M 2004 Targeting estrogen responsive elements (EREs): design of potent transactivators for EREcontaining genes. Molecular and Cellular Endocrinology 218 65-78.
36. Jabara AG 1962 Induction of canine ovarian tumours by diethylstilboestrol and progesterone. Australian Journal of Experimental Biology and Medical Science 40 139-152.
37. Kondoh K, Tsuji N, Asanuma K, Kobayashi D & Watanabe N 2007 Inhibition of estrogen receptor b-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)- prostaglandin J(2)-induced apoptosis in cancer cells. Experimental Cell Research 313 3486-3496.
38. Kossowska-Tomaszczuk K, De Geyter C, De Geyter M, Martin I, Holzgreve W, Scherberich A & Zhang H 2009 The multipotency of luteinizing granulosa cells collected from mature ovarian follicles. Stem Cells 27 210-219.
39. Kusakari T, Kariya M, Mandai M, Tsuruta Y, Hamid AA, Fukuhara K, Nanbu K, Takakura K & Fujii S 2003 C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. British Journal of Cancer 89 2293-2298.
40. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A & Inoue M 1999 Estrogen activates telomerase. Cancer Research 59 5917-5921.
41. Lacey JV Jr,Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A & Schairer C 2002 Menopausal hormone replacement therapy and risk of ovarian cancer. Journal of the American Medical Association 288 334-341. (Pubitemid 34761612)
42. Lacham-Kaplan O, Chy H & Trounson A 2006 Testicular cell conditioned medium supports differentiation of embryonic stem cells into ovarian structures containing oocytes. Stem Cells 24 266-273.
43. de Lange T 2005 Shelterin: the protein complex that shapes and safeguards human telomeres. Genes and Development 19 2100-2110.
44. Laviolette LA, Garson K, Macdonald EA, Senterman MK, Courville K, Crane CA & Vanderhyden BC 2010 17b-Estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer. Endocrinology 151 929-938.
45. Lavranos TC, Mathis JM, Latham SE, Kalionis B, Shay JW & Rodgers RJ 1999 Evidence for ovarian granulosa stem cells: telomerase activity and localization of the telomerase ribonucleic acid component in bovine ovarian follicles. Biology of Reproduction 61 358-366.
46. Lee HW, Blasco MA, Gottlieb GJ, Horner JW II, Greider CW & DePinho RA 1998 Essential role of mouse telomerase in highly proliferative organs. Nature 392 569-574.
47. Lee ST, Choi MH, Lee EJ, Gong SP, Jang M, Park SH, Jee H, Kim DY, Han JY & Lim JM 2008 Establishment of autologous embryonic stem cells derived from preantral follicle culture and oocyte parthenogenesis. Fertility and Sterility 90 1910-1920.
48. Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F, Nadal-Ginard B, Kajstura J, Anversa P & Blasco MA 2003 Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO Journal 22 131-139.
49. Li H & Liu JP 2007 Mechanisms of action of TGF-b in cancer: evidence for Smad3 as a repressor of the hTERT gene. Annals of the New York Academy of Sciences 1114 56-68. (Pubitemid 350070383)
50. Li NF, Broad S, Lu YJ, Yang JS, Watson R, Hagemann T, Wilbanks G, Jacobs I, Balkwill F, Dafou D et al. 2007 Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression. Cell Proliferation 40 780-794. (Pubitemid 47416552)
51. Li YF, Hu W, Fu SQ, Li JD, Liu JH & Kavanagh JJ 2008 Aromatase inhibitors in ovarian cancer: is there a role? International Journal of Gynecological Cancer 18 600-614.
52. Ling S, Zhou L, Li H, Dai A, Liu JP, Komesaroff PA & Sudhir K 2006 Effects of 17b-estradiol on growth and apoptosis in human vascular endothelial cells: influence of mechanical strain and tumor necrosis factor-a. Steroids 71 799-808.
53. Liu L, Blasco M, Trimarchi J & Keefe D 2002 An essential role for functional telomeres in mouse germ cells during fertilization and early development. Developmental Biology 249 74-84.
54. Liu L, Bailey SM, Okuka M, Munoz P, Li C, Zhou L, Wu C, Czerwiec E, Sandler L, Seyfang A et al. 2007 Telomere lengthening early in development. Nature Cell Biology 9 1436-1441.
55. Liu JP, Nicholls C, Chen SM, Li H & Tao ZZ 2010 Strategies of treating cancer by cytokine regulation of chromosome end remodelling. Clinical and Experimental Pharmacology and Physiology 37 88-92.
56. Lue NF 2009 Closing the feedback loop: how cells "count" telomere-bound proteins. Molecular Cell 33 413-414.
57. Maeda T, Tashiro H, Katabuchi H, Begum M, Ohtake H, Kiyono T & Okamura H 2005 Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability. British Journal of Cancer 93 116-123.
58. Marx J 2008 Developmental biology. Aging of the ovary linked to PTEN pathway. Science 319 558-559.
59. McGee EA & Hsueh AJW 2000 Initial and cyclic recruitment of ovarian follicles. Endocrine Reviews 21 200-214.
60. Misiti S, Nanni S, Fontemaggi G, Cong YS, Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bacchetti S et al. 2000 Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Molecular and Cellular Biology 20 3764-3771.
61. Munstedt K, Steen J, Knauf AG, Buch T, von Georgi R & Franke FE 2000 Steroid hormone receptors and long term survival in invasive ovarian cancer. Cancer 89 1783-1791.
62. Olovnikov AM 1996 Telomeres, telomerase, and aging: origin of the theory. Experimental Gerontology 31 443-448.
63. Palter SF, Tavares AB, Hourvitz A, Veldhuis JD & Adashi EY 2001 Are estrogens of import to primate/human ovarian folliculogenesis? Endocrine Reviews 22 389-424.
64. Piontkewitz Y, Sundfeldt K & Hedin L 1997 The expression of c-myc during follicular growth and luteal formation in the rat ovary in vivo. Journal of Endocrinology 152 395-406. (Pubitemid 27102204)
65. Qing T, Shi Y, Qin H, Ye X, Wei W, Liu H, Ding M & Deng H 2007 Induction of oocyte-like cells from mouse embryonic stem cells by co-culture with ovarian granulosa cells. Differentiation 75 902-911. (Pubitemid 350214449)
66. Reddy P, Liu L, Adhikari D, Jagarlamudi K, Rajareddy S, Shen Y, Du C, Tang W, Hamalainen T, Peng SL et al. 2008 Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science 319 611-613. (Pubitemid 351197061)
67. Russo V, Berardinelli P, Martelli A, Di Giacinto O, Nardinocchi D, Fantasia D & Barboni B 2006 Expression of telomerase reverse transcriptase subunit (TERT) and telomere sizing in pig ovarian follicles. Journal of Histochemistry and Cytochemistry 54 443-455.
68. Santos GF, Scott GK, Lee WM, Liu E & Benz C 1988 Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. Journal of Biological Chemistry 263 9565-9568.
69. Sarkar P, Shiizaki K, Yonemoto J & Sone H 2006 Activation of telomerase in BeWo cells by estrogen and 2,3,7,8-tetrachlorodibenzo-p-dioxin in co-operation with c-Myc. International Journal of Oncology 28 43-51.
70. Sasaki R, Narisawa-Saito M, Yugawa T, Fujita M, Tashiro H, Katabuchi H & Kiyono T 2009 Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.Carcinogenesis 30423-431.
71. Shay JW 1999 Toward identifying a cellular determinant of telomerase repression [editorial; comment]. Journal of the National Cancer Institute 91 4-6.
72. Shay JW & Bacchetti S 1997 A survey of telomerase activity in human cancer. European Journal of Cancer 33 787-791. (Pubitemid 27239490)
73. Shay JW & Wright WE 2005 Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26 867-874. (Pubitemid 41214314)
74. Shay JW & Wright WE 2007 Hallmarks of telomeres in ageing research. Journal of Pathology 211 114-123.
75. Silva EG, Tornos C, Deavers M, Kaisman K, Gray K & Gershenson D 1998 Induction of epithelial neoplasms in the ovaries of guinea pigs by estrogenic stimulation. Gynecologic Oncology 71 240-246.
76. Soslow RA 2008 Histologic subtypes of ovarian carcinoma: an overview. International Journal of Gynecological Pathology 27 161-174.
77. Szostak JW & Blackburn EH 1982 Cloning yeast telomeres on linear plasmid vectors. Cell 29 245-255.
78. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT & Donahoe PK 2006 Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. PNAS 103 11154-11159.
79. Tilgner K, Atkinson SP, Golebiewska A, Stojkovic M, Lako M & Armstrong L 2008 Isolation of primordial germ cells from differentiating human embryonic stem cells. Stem Cells 26 3075-3085.
80. Tomanek M, Chronowska E, Kott T & Czernekova V 2008 Telomerase activity in pig granulosa cells proliferating and differentiating in vitro. Animal Reproduction Science 104 284-298.
81. Venteicher AS, Abreu EB, Meng Z, McCann KE, Terns RM, Veenstra TD, Terns MP & Artandi SE 2009 A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 323 644-648.
82. Virant-Klun I, Rozman P, Cvjeticanin B, Vrtacnik-Bokal E, Novakovic S, Rulicke T, Dovc P & Meden-Vrtovec H 2009 Parthenogenetic embryolike structures in the human ovarian surface epithelium cell culture in postmenopausal women with no naturally present follicles and oocytes. Stem Cells and Development 18 137-150.
83. Weihua Z, Andersson S, Cheng G, Simpson ER, Warner M & Gustafsson JA 2003 Update on estrogen signaling. FEBS Letters 546 17-24.
84. Wong JM & Collins K 2003 Telomere maintenance and disease. Lancet 362 983-988.
85. Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, Gu Y, Alt FW & DePinho RA 2003 Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421 643-648.
86. Xu J & Yang X 2000 Telomerase activity in bovine embryos during early development. Biology of Reproduction 63 1124-1128.
87. Yamagata Y, Nakamura Y, Umayahara K, Harada A, Takayama H, Sugino N & Kato H 2002 Changes in telomerase activity in experimentally induced atretic follicles of immature rats. Endocrine Journal 49 589-595. (Pubitemid 36119577)
88. Yang H, Ou CC, Feldman RI, Nicosia SV, Kruk PA & Cheng JQ 2004 Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Research 64 463-467.
89. Yang G, Rosen DG, Colacino JA, Mercado-Uribe I & Liu J 2007a Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells. Oncogene 26 1492-1498.
90. Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast RC Jr, Zhou C & Liu J 2007b Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Carcinogenesis 28 174-182. (Pubitemid 44942641)
91. Yokoyama Y, Takahashi Y, Shinohara A, Lian Z & Tamaya T 1998 Telomerase activity in the female reproductive tract and neoplasms. Gynecologic Oncology 68 145-149. (Pubitemid 28150764)
92. Young TW, Mei FC, Yang G, Thompson-Lanza JA, Liu J & Cheng X 2004 Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry. Cancer Research 64 4577-4584. (Pubitemid 38856931)
93. Zhao Y, Hoshiyama H, Shay JW & Wright WE 2008 Quantitative telomeric overhang determination using a double-strand specific nuclease. Nucleic Acids Research 36 e14.
94. Zhou C & Liu J 2003 Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells. Biochemical and Biophysical Research Communications 303 130-136.
95. Zou K, Yuan Z, Yang Z, Luo H, Sun K, Zhou L, Xiang J, Shi L, Yu Q, Zhang Y et al. 2009 Production of offspring from a germline stem cell line derived from neonatal ovaries. Nature Cell Biology 11 631-636.